ibr 140 mg (Imbruvica 140 mg)
Generic Name: ibrutinib
Pill imprint ibr 140 mg has been identified as Imbruvica 140 mg.
Imbruvica is used in the treatment of chronic lymphocytic leukemia; mantle cell lymphoma; waldenström macroglobulinemia; non-hodgkin's lymphoma; lymphoma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Imbruvica (ibrutinib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.